NanoMedical Systems

Focus: NanoMedical Systems develops personalized molecular drug-delivery system implants, a specialized medical device focused on targeted therapeutic delivery. The company operates in the emerging nanomedicine space with a precision medicine approach.

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About NanoMedical Systems

AI assessmentNot Hiring

No open roles listed right now. Follow NanoMedical Systems to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

0/9 — Limited

Company HealthSolid

Pipeline

Early-stage

0 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Open Jobs (0)

No open positions listed yet.

Help build intelligence for NanoMedical Systems

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Ground-floor opportunity in personalized drug-delivery—a high-growth frontier with limited competition and significant IP potential
Medical device + pharma hybrid space offers unique cross-functional exposure to regulatory pathways (FDA), manufacturing scale-up, and precision medicine
Austin location provides tech talent ecosystem and lower cost-of-living than coastal biotech hubs

Watch Out For

No active clinical trials, products, or revenue reported—indicates pre-clinical or very early stage with execution risk and longer path to meaningful milestones
Minimal public data on funding, employee count, or hiring activity suggests either stealth-mode operations or low capitalization; career stability and advancement velocity unclear
Zero current job openings indicates either paused hiring or very early-stage operations with limited near-term growth opportunities

Generated by Claude from NanoMedical Systems's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo